SRSF3 and myocardial infarction: Therefore, the pathway by which miR‐486 targets SRSF3/p21 to mediate the senescence of CMFs is a potential therapeutic target to improve the fibrotic activity and pathological fibrosis and remodelling seen in ischaemic myocardium, such as MI, to promote increased regeneration.